Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (596)	7/29/2004 2:25:51 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

FHRX Is also up 15% after it reported its 2ndQ earnings, which were more than 180% better than on the 2ndQ of 2003($0.15 vs.a loss of $0.18)and revenues were up more than 70% (36M vs. 21M) The EE for 2004 are around $$0.57 vs, loss of $0.16 in 2003 and EE for 2005 are around $0.70 FHRX still has around $150M of LTD, but has now a positive cash flow and has announced a share repurchase program, of up to $20M over the next 12 months (about $5M/Q.<g>) The insiders reportedly hold more than 25% and institutions close to 80% of the float. The short ratio had been recently around 10% of the float.<g> bigcharts.marketwatch.com Bernard